# Telo Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/telo-therapeutics

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.telotherapeutics.com
- Total disclosed funding: $4.2M
- Latest round: Seed (Jun 9, 2021)
- Investors on record: 1

## About

Founded in 2015 and based in California, US, Telo Therapeutics, Inc. operates as a therapeutic research company that specializes novel precision medicine for Oncology. The firm was founded by Robert Bell and Joseph Costello. In June 2021, Telo Therapeutics, Inc. raised USD 4.20 million in seed funding from Mission BioCapital. 



The company creates and sells medicines that specialize in inhibiting cancer cell immortality by immortalizing healthy cells while leaving cancer cells alone to help reverse cancer cell immortality. The company's therapies are aimed to treat fatal diseases such as cancer.

## Funding rounds

- Seed, Jun 9, 2021, $4.2M — Mission Biocapital

## Investors

- Mission Biocapital (https://capitalatlas.ai/funds/mission-biocapital) — Seed